Fund detail
Baillie Gifford
large-active, growth, lo
Quarters
52
2023-06-30
$117.64B
Positions
297
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↓ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2seventy bio | $0 | 0 | -286 | -100.00% | 0.00% | ||||||
| 2 | 8x8 Inc | $0 | 0 | -2,045 | -100.00% | 0.00% | ||||||
| 3 | 908 Devices | $0 | 0 | -249 | -100.00% | 0.00% | ||||||
| 4 | A. O. Smith | $0 | 0 | -289 | -100.00% | 0.00% | ||||||
| 5 | Acadia Pharmaceuticals Inc | $0 | 0 | -618 | -100.00% | 0.00% | ||||||
| 6 | Accelerate Diagnostics | $0 | 0 | -418 | -100.00% | 0.00% | ||||||
| 7 | Accenture 'A' | $0 | 0 | -48 | -100.00% | 0.00% | ||||||
| 8 | ACM Research | $0 | 0 | -660 | -100.00% | 0.00% | ||||||
| 9 | Acutus Medical | $0 | 0 | -424 | -100.00% | 0.00% | ||||||
| 10 | Adeia Inc | $0 | 0 | -1,448 | -100.00% | 0.00% | ||||||
| 11 | Agios Pharmaceuticals Inc | $0 | 0 | -186 | -100.00% | 0.00% | ||||||
| 12 | Alteryx Inc | $0 | 0 | -383 | -100.00% | 0.00% | ||||||
| 13 | Amdocs | $0 | 0 | -432 | -100.00% | 0.00% | ||||||
| 14 | Amicus Therapeutics Inc | $0 | 0 | -538 | -100.00% | 0.00% | ||||||
| 15 | Amkor Technology | $0 | 0 | -2,043 | -100.00% | 0.00% | ||||||
| 16 | Anterix | $0 | 0 | -162 | -100.00% | 0.00% | ||||||
| 17 | Apellis Pharmaceuticals | $0 | 0 | -325 | -100.00% | 0.00% | ||||||
| 18 | Asensus Surgical Inc | $0 | 0 | -5,338 | -100.00% | 0.00% | ||||||
| 19 | AstraZeneca ADR | $0 | 0 | -456 | -100.00% | 0.00% | ||||||
| 20 | Avery Dennison Corporation | $0 | 0 | -132 | -100.00% | 0.00% | ||||||
| 21 | Axonics Modulation Technologies | $0 | 0 | -198 | -100.00% | 0.00% | ||||||
| 22 | BioCryst Pharmaceuticals | $0 | 0 | -1,687 | -100.00% | 0.00% | ||||||
| 23 | Blackrock Inc | $0 | 0 | -26 | -100.00% | 0.00% | ||||||
| 24 | Blink Charging | $0 | 0 | -396 | -100.00% | 0.00% | ||||||
| 25 | Bluebird Bio Inc | $0 | 0 | -860 | -100.00% | 0.00% | ||||||
| 26 | Blueprint Medicines Corp | $0 | 0 | -315 | -100.00% | 0.00% | ||||||
| 27 | Boston Omaha | $0 | 0 | -676 | -100.00% | 0.00% | ||||||
| 28 | Box Inc | $0 | 0 | -1,047 | -100.00% | 0.00% | ||||||
| 29 | Bristol Myers Squibb | $0 | 0 | -531 | -100.00% | 0.00% | ||||||
| 30 | Brunswick Corp | $0 | 0 | -243 | -100.00% | 0.00% |